Commentary on Trastuzumab deruxtecan in the treatment of adult patients with HER-positive breast cancer

Maciej Krzakowski

Vol 19, No 5 (2023)

Commentary

Dual-organ toxicity during treatment with nivolumab and ipilimumab in combination with chemotherapy in the first-line treatment of non-small cell lung cancer

Agnieszka Dyzma-Kasprzak, Karol Kasprzak, Elżbieta Szczepaniak-Wójtowicz, Joanna Milanowska, Izabela Chmielewska, Paweł Krawczyk

Online first

Case report

When stents kiss — management of bilateral ureteral obstruction

Paweł Buraczyński, Marcin Czeczelewski, Ewa Kopyto, Łukasz Światłowski, Krzysztof Pyra

Online first

Clinical vignette

An early diagnosed medulloblastoma of the vermis

Mansour Parvaresh, Hesam Ghadirian, Arash Fattahi, Alireza Sadeghipour

Online first

Case report

Preservation of vision through an interdisciplinary approach: a case report of intraorbital malignant solitary fibrous tumor

Andrzej Jarząbski, Tomasz Łysoń, Dorota Kiprian, Joanna Turkiewicz, Daria Kamińska, Andrzej Kawecki

Online first

Case report

Locally advanced thoracic NUT carcinoma — a case report and literature review

Piotr A. Chilczuk, Magdalena Knetki-Wróblewska

Online first

Case report

Umbrella trials as a novel concept of cancer clinical trials — a systematic review

Mikołaj Bartoszkiewicz, Joanna Kufel-Grabowska, Paweł Burchardt

Online first

Review paper

Efficacy of targeted therapies in the treatment of patients with melanoma harboring BRAF V600 mutation with central nervous system metastases

Monika Dudzisz-Śledź, Piotr Rutkowski

Vol 20, Supp. A (2024)

Review paper

A case of a patient treated with targeted therapy in brain metastases of melanoma with BRAF V600 mutation

Jan Żurawski

Vol 20, Supp. A (2024)

Case report

Melanoma of unknown origin with central nervous system metastases

Marta Pabianek, Magdalena Ciążyńska

Vol 20, Supp. A (2024)

Case report

Response to encorafenib and binimetinib therapy after prior treatment with targeted therapy and immunotherapy in melanoma patient with brain metastases

Łukasz Galus

Vol 20, Supp. A (2024)

Case report

Introduction

Piotr Rutkowski

Vol 20, Supp. A (2024)

Other materials agreed with the Editors

Encorafenib in combination with binimetinib in second line palliative treatment in 44-year patient with symptoms of spinal cord compression

Joanna Lompart

Vol 20, Supp. A (2024)

Case report

Treatment with encorafenib and binimetinib of elderly female patient with BRAF-mutated melanoma with central nervous system metastases

Monika Dudzisz-Śledź

Vol 20, Supp. A (2024)

Case report

Effectiveness of rechallenge with BRAF/ /MEK inhibitors in patient with advanced melanoma with BRAF V600 mutation

Katarzyna Woźniak

Vol 20, Supp. A (2024)

Case report

Patient with M1d melanoma treated with encorafenib and binimetinib with partial response in the second line

Paulina Jagodzińska-Mucha

Vol 20, Supp. A (2024)

Case report

Treatment of advanced skin melanoma with BRAF V600 mutation with central nervous system metastases with encorafenib in combination with binimetinib

Natasza Kempa-Kamińska

Vol 20, Supp. A (2024)

Case report